Unison Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,324
Closed -$3.02M 181
2026
Q1
$3.02M Buy
11,324
+32
+0.3% +$8.66K 0.23% 53
2025
Q4
$2.83M Buy
11,292
+27
+0.2% +$7.17K 0.25% 46
2025
Q3
$3.23M Buy
11,265
+30
+0.3% +$8.04K 0.3% 43
2025
Q2
$2.95M Buy
11,235
+35
+0.3% +$8.52K 0.33% 43
2025
Q1
$2.61M Buy
11,200
+33
+0.3% +$8.01K 0.33% 50
2024
Q4
$2.56M Buy
11,167
+36
+0.3% +$8.26K 0.3% 52
2024
Q3
$2.49M Buy
11,131
+38
+0.3% +$8.35K 0.3% 57
2024
Q2
$2.26M Buy
11,093
+40
+0.4% +$8.14K 0.28% 62
2024
Q1
$2.41M Buy
11,053
+51
+0.5% +$11.2K 0.24% 55
2023
Q4
$2.5M Buy
11,002
+38
+0.3% +$7.98K 0.27% 48
2023
Q3
$2.2M Sell
10,964
-1,761
-14% -$371K 0.26% 52
2023
Q2
$2.64M Buy
12,725
+39
+0.3% +$7.57K 0.29% 45
2023
Q1
$2.5M Buy
12,686
+46
+0.4% +$9.47K 0.28% 47
2022
Q4
$2.56M Buy
12,640
+43
+0.3% +$8.4K 0.33% 42
2022
Q3
$2.22M Buy
+12,597
New +$2.58M 0.41% 43

Other funds holding LH

Unison Advisors's LH Position: Q2 2026 in Review

Unison Advisors sold out of Labcorp (LH) in Q2 2026, closing a stake of 11,324 shares — an estimated $3.02M sold.

Unison Advisors first reported a position in LH in Q3 2022 and held it in 15 quarters. The position peaked at $3.23M in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Unison Advisors reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Unison Advisors sold 11,324 Labcorp shares in Q2 2026, an estimated $3.02M.
  • Unison Advisors first reported a position in Labcorp in Q3 2022 and held it in 15 quarters.
  • Unison Advisors's Labcorp position peaked at $3.23M in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Unison Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.